A phase 2 human clinical trial of an antigen for a parasitic infection caused by hookworms has been shown to be effective in ...
A phase 2 human clinical trial of an antigen for a parasitic infection caused by hookworms has been shown to be effective in ...
A phase 2 clinical trial has shown that a candidate hookworm vaccine can significantly reduce infection intensity, marking a milestone after decades of research. The development coincides with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results